ATE358719T1 - Hefebehandlung - Google Patents

Hefebehandlung

Info

Publication number
ATE358719T1
ATE358719T1 AT03812529T AT03812529T ATE358719T1 AT E358719 T1 ATE358719 T1 AT E358719T1 AT 03812529 T AT03812529 T AT 03812529T AT 03812529 T AT03812529 T AT 03812529T AT E358719 T1 ATE358719 T1 AT E358719T1
Authority
AT
Austria
Prior art keywords
liposome
molar
lipid bilayer
yeast treatment
liposome lipid
Prior art date
Application number
AT03812529T
Other languages
English (en)
Inventor
Michael Patane
Original Assignee
Protech Res Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Protech Res Pty Ltd filed Critical Protech Res Pty Ltd
Application granted granted Critical
Publication of ATE358719T1 publication Critical patent/ATE358719T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/14—Yeasts or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
  • Medicinal Preparation (AREA)
  • Seasonings (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
AT03812529T 2002-12-12 2003-12-04 Hefebehandlung ATE358719T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU2002953285A AU2002953285A0 (en) 2002-12-12 2002-12-12 Yeast treatment

Publications (1)

Publication Number Publication Date
ATE358719T1 true ATE358719T1 (de) 2007-04-15

Family

ID=30004370

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03812529T ATE358719T1 (de) 2002-12-12 2003-12-04 Hefebehandlung

Country Status (9)

Country Link
US (1) US20040147028A1 (de)
EP (1) EP1573001B1 (de)
JP (1) JP2006509501A (de)
AT (1) ATE358719T1 (de)
AU (1) AU2002953285A0 (de)
DE (1) DE60313031T2 (de)
ES (1) ES2285271T3 (de)
NZ (1) NZ541173A (de)
WO (1) WO2004053118A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006063411A2 (en) * 2004-12-16 2006-06-22 Protech Research Pty Ltd Transfer of molecules
WO2006132350A1 (ja) * 2005-06-09 2006-12-14 National Institute Of Advanced Industrial Science And Technology 分泌型発光酵素を用いたレポーターアッセイ
AU2006291429B2 (en) * 2005-09-15 2013-04-04 Biontech Delivery Technologies Gmbh Improvements in or relating to amphoteric liposomes
CA2656228C (en) * 2006-06-30 2016-02-09 Hokkaido System Science Co., Ltd. Composition for nucleic-acid transfection
WO2010143969A2 (en) * 2009-06-08 2010-12-16 Epitarget As Acoustically sensitive drug delivery particles comprising non-lamellar forming phosphatidylethanolamine
WO2010143972A2 (en) * 2009-06-08 2010-12-16 Epitarget As Acoustically sensitive drug delivery particles comprising non-lamellar forming lipids
EP2440182A2 (de) * 2009-06-08 2012-04-18 Epitarget AS Lipophile wirkstoffträger
WO2012159704A1 (en) * 2011-05-20 2012-11-29 Merck Patent Gmbh Stable crystal modifications of dotap chloride

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4789633A (en) * 1984-04-19 1988-12-06 University Of Tennessee Research Corporation Fused liposome and acid induced method for liposome fusion
JPS62201595A (ja) * 1986-01-29 1987-09-05 Sanyo Kokusaku Pulp Co Ltd 酵母エキスの製造法
US5698721A (en) * 1992-12-17 1997-12-16 Megabios Corporation Catonic amphiphiles
WO1995031183A1 (en) * 1994-05-16 1995-11-23 Washington University Cell membrane fusion composition and method
JP2002508765A (ja) * 1997-06-23 2002-03-19 アルザ コーポレイション リポソーム被包ポリヌクレオチド組成物および方法
JP3243508B2 (ja) * 1999-09-10 2002-01-07 独立行政法人産業技術総合研究所 濃度測定方法
US6673564B2 (en) * 1999-10-18 2004-01-06 Millennium Pharmaceuticals, Inc. Methods for using 22045, a human cyclic nucleotide phosphodiesterase
AU2001284902A1 (en) * 2000-08-15 2002-02-25 Zymogenetics Inc. Human adenosine deaminase
US20050163832A1 (en) * 2002-02-13 2005-07-28 Vladimir Torchilin Intracellular delivery of therapeutic agents

Also Published As

Publication number Publication date
EP1573001A4 (de) 2005-11-16
DE60313031D1 (de) 2007-05-16
NZ541173A (en) 2008-07-31
JP2006509501A (ja) 2006-03-23
EP1573001A1 (de) 2005-09-14
DE60313031T2 (de) 2007-12-13
WO2004053118A1 (en) 2004-06-24
EP1573001B1 (de) 2007-04-04
US20040147028A1 (en) 2004-07-29
AU2002953285A0 (en) 2003-01-02
ES2285271T3 (es) 2007-11-16

Similar Documents

Publication Publication Date Title
WO2008109031A8 (en) Liposome carriers for in vivo delivery of fullerenes
AU2002232788A1 (en) Self forming, thermodynamically stable liposomes and their applications
NZ562346A (en) Complexes comprising ApoA-I apolipoprotein, sphingomyelin and a negatively charged phospholipid
AU3559895A (en) Polyethylene glycol modified ceramide lipids and liposome uses thereof
WO1998019709A3 (en) Cationic reagents for transfection
CY1112981T1 (el) Μεθοδος και συνθεση για την αγωγη της ρινιτιδας
AU3900299A (en) Cationic lipids with disulphide bonds for the intracellular delivery of therapeutic substances
WO2004054499A3 (en) Platinum aggregates and process for producing the same
WO2005094783A3 (de) Serumstabile amphotere liposomen
DE60313031D1 (de) Hefebehandlung
ATE198419T1 (de) Etherlipid-liposomen und deren therapeutische verwendung
AU2002236062A1 (en) Lipids, lipid compositions, liposomes, and lipoplexes
DE60114996D1 (de) Senkung des serum cholesterols
DE69332276D1 (de) Liposomenzusammensetzung
DK1135193T3 (da) Middel til tumorterapi, som er baseret på liposomer, og som indeholder tamoxifen
NO983520D0 (no) FremgangsmÕte for fremstilling av lysofosfatidylcholin
TW200714292A (en) Lipid carrier and method of preparing the same
AU2002340670A1 (en) Lipid carrier compositions and methods for improved drug retention
MXPA02012068A (es) Formulaciones liposomales inhibidoras de la timidilato de benzoqunazolina sintasa.
CA2326348A1 (en) Liposomal bupivacaine compositions and methods of preparation
ATE419833T1 (de) Modulares zielgerichtetes liposomales verabreichungssytem
WO2004037223A3 (de) Liposomen formende zusammensetzung
WO2003035032A3 (en) New non-phospholipid lipid vesicles (nplv) and their use in cosmetic, therapeutic and prophylactic applications
ATE318834T1 (de) Lipide mit aminoxygruppe
WO2001041706A3 (en) Lipid nanotubules for topical delivery

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties